Related Experiment Video
Updated: Sep 17, 2025

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
Published on: November 7, 2017
Renal hyperfiltration as risk factor of major adverse cardiovascular events in patients with acute myocardial
Jin Sug Kim1, Weon Kim2, Hyo-Jin Lee1
1Division of Nephrology, Department of Internal Medicine, Kyung Hee University Medical Center, Kyung Hee University College of Medicine, Seoul, Korea.
Insights
Renal hyperfiltration (RHF) in acute myocardial infarction (AMI) patients is linked to increased major adverse cardiovascular events (MACEs) and mortality. Identifying RHF aids in better risk stratification for these patients.
Area of Science:
- Cardiology
- Nephrology
- Clinical Research
Background:
- The interplay between cardiac and renal function is crucial, with renal hyperfiltration (RHF) potentially developing in acute myocardial infarction (AMI) patients.
- The clinical significance of RHF in AMI patients remains incompletely understood.
Purpose of the Study:
- To investigate the association between RHF and major adverse cardiovascular events (MACEs) in patients following AMI.
- To determine the prognostic value of RHF for mortality and cardiac death in the AMI population.
Main Methods:
- Analysis of a large nationwide cohort of 9561 AMI patients with estimated glomerular filtration rate (eGFR) ≥ 60 mL/min/1.73 m².
- RHF defined as eGFR > 90th percentile after adjustments; primary endpoint was 3-year MACEs.
- Multivariable Cox-regression and propensity score-matched analyses were employed.
Main Results:
- Patients with RHF exhibited a significantly higher cumulative incidence of MACEs.
- RHF was independently associated with a 1.34-fold increased risk of MACEs (95% CI 1.12-1.62).
- RHF significantly elevated the risk of all-cause mortality (HR 1.64) and cardiac death (HR 1.78), with a U-shaped association observed for MACE risk and eGFR levels above 100 mL/min/1.73 m².
Conclusions:
- Renal hyperfiltration is an independent risk factor for adverse cardiovascular outcomes in AMI patients.
- These findings enhance risk stratification strategies for AMI patients by incorporating RHF assessment.
- The study highlights the importance of considering renal function beyond standard thresholds in cardiovascular risk evaluation.
Abstract:
The potential interaction between the heart and kidneys is thought to contribute to the development of renal hyperfiltration (RHF). However, the clinical implications of RHF remain unclear in patients with acute myocardial infarction (AMI). A total of 9561 AMI patients with estimated glomerular filtration rate (eGFR) ≥ 60 mL/min/1.73 m2 were enrolled from a large nationwide cohort. RHF was defined as eGFR > 90th percentile after multiple adjustments. The primary endpoint was a combination of 3 year major adverse cardiovascular events (MACEs) after AMI treatment. The cumulative event rate of MACEs was significantly higher in patients with RHF. In multivariable Cox-regression analysis, RHF increased the 1.34-fold risk of MACE (95% confidence interval [CI] 1.12-1.62) compared to those without RHF. Patients with RHF had a significantly higher risk of all-cause mortality (hazard ratio [HR] 1.64; 95% CI 1.25-2.14) and cardiac death (HR 1.78; 95% CI 1.26-2.51). There was a U-shaped association between the adjusted risk of MACEs and eGFR, with the risk increasing as eGFR exceeded approximately 100 mL/min/1.73 m2. The results demonstrated a consistent pattern in the 1:1 PS-matched population. Our study offers new insights into the risk stratification of AMI patients with RHF.
Related Concept Videos
Heart Failure V: Medical Management
Heart Failure Drugs: Diuretics
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury VI: Nursing Management
Cardiac Catheterization I: Pre-Procedure Overview
Hemodialysis II: Procedure and Complications

